Human T-bet+ B cell development is associated with BTK activity and suppressed by evobrutinib.

JCI Insight · 2022 · PMC9462504 · PMID 35852869

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

CXCR4 and CXCR5 remained unaffected, whereas VLA-4 showed a trend toward decreased expression ( Figure 5A and Supplemental Figure 6A ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.